Laboratory Medicine and Quality Assurance

Table. 2.

Acceptable rates based on urine analyzers of different companies

Instrument No. (%) pH Protein Glucose Ketone Bilirubin Blood Urobilinogen Nitrite Leukocyte
1st proficiency test
YD 626 (39.4) 95.5 97.5 95.9 99.5 99.4 99.3 43.3 99.6 98.7
Abbott 380 (23.9) 98.3 76.5 97.3 99.7 99.0 99.4 70.9 99.8 99.7
Roche 182 (11.5) 85.6 98.0 99.5 99.8 99.9 99.1 71.7 99.2 99.4
DFI 144 (9.1) 97.0 83.3 99.0 99.8 99.1 98.8 69.8 98.8 97.9
Sysmex 109 (6.9) 91.3 98.2 100.0 100.0 100.0 99.8 56.9 99.8 99.6
Siemens 108 (6.8) 80.1 97.7 94.9 100.0 86.3 98.4 47.9 99.1 99.6
Eiken 14 (0.9) 82.5 91.3 98.8 100.0 86.1 98.8 72.2 100.0 100.0
Arkray 16 (1.0) 100.0 95.3 100.0 100.0 75.0 95.3 21.9 100.0 100.0
Beckman 9 (0.6) 97.2 88.9 100.0 97.2 80.6 94.5 47.2 97.2 100.0
2nd proficiency test
YD 622 (39.0) 94.7 99.5 96.0 99.8 99.5 99.3 50.1 99.8 98.6
Abbott 397 (24.9) 97.9 78.5 97.5 99.6 99.5 99.5 93.7 99.8 99.1
Roche 178 (11.2) 86.1 100.0 99.7 100.0 99.9 99.2 96.8 99.6 99.3
DFI 142 (8.9) 96.5 83.9 98.5 99.7 99.1 98.1 89.8 98.5 98.1
Sysmex 112 (7.0) 86.4 99.8 100.0 100.0 100.0 100.0 76.8 100.0 100.0
Siemens 107 (6.7) 85.8 99.6 92.8 99.8 84.8 98.6 62.2 99.1 99.3
Eiken 15 (0.9) 92.1 98.7 98.7 100.0 91.2 100.0 95.6 98.5 100.0
Arkray 15 (0.9) 100.0 100.0 100.0 100.0 76.7 98.3 45.0 100.0 100.0
Beckman 8 (0.5) 100.0 96.9 100.0 100.0 71.9 100.0 84.4 100.0 100.0
3rd proficiency test
YD 628 (39.1) 97.4 99.6 97.1 99.7 99.1 98.9 50.0 99.6 98.8
Abbott 400 (24.9) 97.3 93.4 97.7 99.7 99.6 99.5 94.3 99.8 99.7
Roche 177 (11.0) 84.1 99.9 99.7 100.0 100.0 99.7 88.6 99.6 100.0
DFI 143 (8.9) 95.1 88.1 99.6 100.0 98.8 98.9 90.1 99.1 99.2
Sysmex 115 (7.2) 99.8 100.0 100.0 100.0 99.8 99.8 76.3 100.0 100.0
Siemens 103 (6.4) 83.0 100.0 99.5 100.0 84.2 99.8 64.3 99.8 99.8
Eiken 16 (1.0) 96.1 100.0 100.0 100.0 100.0 97.4 95.4 100.0 100.0
Arkray 17 (1.1) 98.5 100.0 100.0 100.0 75.0 98.5 30.9 100.0 100.0
Beckman 8 (0.5) 100.0 100.0 100.0 100.0 56.3 100.0 71.9 100.0 100.0

Values are presented as percentages or numbers (%). The results with <90% accuracy are indicated in bold. The instruments used were as follows: YD (YD Diagnostics, Yongin, Korea), Abbott (Abbott Laboratories, Abbott Park, IL, USA), Roche (Roche Diagnostics, Mannheim, Germany), DFI (DFI Co. Ltd., Gimhae, Korea), Symex (Symex Co., Kobe, Japan), Siemens (Siemens Healthcare, Erlangen, Germany), Eiken (Eiken Chemical Co., Tokyo, Japan), Arkray (Arkray Inc., Kyoto, Japan), and Beckman (Beckman Coulter Inc., Brea, CA, USA).

Lab Med Qual Assur 2023;45:1~9 https://doi.org/10.15263/jlmqa.2023.45.1.1
© Lab Med Qual Assur